Clinical Trial Update: Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating swallowing outcomes and circulating tumor DNA in HPV-related oropharyngeal cancer treated with transoral surgery and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinical Hpv-mediated Oropharyngeal Carcinoma
• Hpv-mediated Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: UNKNOWN